A procedure to extract and purify gangliosides from small volumes of plasma (0'6 mL), cerebrospinal fluid (l mL) and fibroblasts is described. Gangliosides were extracted with chloroform/methanol and purified by means of reversed phase chromatography and gel filtration before analysis by thin layer chromatography. The procedure proved to be useful in confirming deficiency of lysosomal enzyme activity affecting ganglioside breakdown. The new procedure also appeared to be useful to monitor ganglioside catabolism in cultured fibroblasts loaded with ganglioside.
Gangliosides are glycosphingolipids characterized by the presence of one or more sialic acid units in the oligosaccharide chain. As components of the plasma membrane, they contribute to the carbohydrate rich glycocalyx that contributes to the surface properties of cells. Gangliosides are present in high concentration in brain grey matter, but are also found in lower concentration in other tissues like liver.' Gangliosidoses are a group of lysosomal diseases, where gangliosides accumulate in tissues due to a deficiency of a carbohydrate releasing enzyme or deficiency of an activator protein.l-' These gangliosidoses are usually diagnosed by measuring enzyme activity using water soluble artificial substrates. Cases of gangliosidoses due to deficiency of the activator protein, however, cannot be diagnosed by such enzyme assays. As yet there are no simple assays available for the activator protein.
In order to study ganglioside storage under pathological conditions, it is necessary to determine the concentration and composition of these lipids in body fluids (plasma, cerebrospinal fluid). Due to the solubility characteristics and low concentrations of gangliosides in plasma, cerebrospinal fluid (CSF) and fibroblasts, it is difficult to obtain ganglioside extracts free from contaminants. Several methods to extract, Correspondence: J G N de Jong. 68 purify and analyse gangliosides from serum or plasma have been reported."? All methods use a total lipid extraction as the first step. Gangliosides are then separated from other lipids by a partition procedure and further purified from contaminants. Ladisch and Gillardv? described the purification of gangliosides from 1 mL of plasma extract by a partition procedure using diisopropyl ether/ I-butanol/aqueous NaCI, followed by a gel filtration step. Dacrernont ' used the lipid extraction and partition procedure described by Folch et al. 8 for 10-50 mL plasma samples. The ganglioside fraction was further purified by silicic acid chromatography.
We present a procedure to extract and purify gangliosides from small volumes of plasma (0'6mL), CSF (I'OmL) and fibroblasts (10 6 cells). The procedure consists of a total lipid extraction step, a partition procedure followed by reversed phase chromatography and gel filtration on small columns and finally thin layer chromatography (TLC) analysis.
MATERIALS AND METHODS

Materials
Ganglioside abbreviations follow the nomenclature of Svennerholm.? G M I , G M3 , G DI • and G T 1b were obtained from Sigma Chemical Company (St Louis, USA; product numbers G-764I, G-5642,G-2392and G-3767, respectively); G M2 from Boehringer-Mannheim (Germany; product number 1087428); chloroform, methanol (pro analyse quality) and HPTLC glass plates, coated with silica gel type 60 without fluorescence indicator, were obtained from E Merck (Darmstadt, Germany); Sep-Pak CIS cartridges were obtained from Waters, division of Millipore, (Milford, MA, USA; Sephadex G25-M PDIO gel filtration columns (bed volume 9· I mL, bed height 5 ern) were from Pharmacia (Uppsala, Sweden). Table 1 shows the age and diagnosis of patients studied. Patients were diagnosed on the basis of clinical symptoms and deficient activity of the respective enzymes in leukocytes. Fibroblast loading experiments were performed on cells from an infantile GM 2-gangliosidosis (case 4).
Patients
Extraction and purification of gangliosides
Plasma (0' 6 mL) was extracted by adding 10 volumes of chloroformlmethanol (C/M) 1I 1 vlv, vortexing for IO min followed by sonication for 10 min in a bath and a second vortexing for 10 min. After centrifugation at 670 x g for 10 min the residue was reextracted with 5 vol of C/M 2/1 vivas above. To the combined supernatants 5 vol each of chloroform and deionized water were added. The resulting two-phase system was alternately vortexed and sonicated for 2 min to achieve a Folch partition.SAfter centrifugation, the upper (aqueous) phase, containing the gangliosides, was quantitatively transferred to another tube. The lower organic phase was reextracted three times with 6 vol of M/HP 1/1 (v/v). The combined four upper phases were brought to a concentration of O· 1 M KCl by adding solid KCl and applied to a SepPak CIS cartridge as described by Williams and McCluer 10 (preconditioned by washing three times with 10 mL of methanol, three times with 20 mL of C/M 2/1 vIv and finally with 10 mL of methanol and 10 mL of C/M/Hp 3/48/47 vlvlv containing 0'1 M KCl). The eluate was reapplied to the column twice, thus assuring that gangliosides were quantitatively absorbed onto the column. Salts and other contaminants were washed from the column using 15 mL of deionized water. Gangliosides were eluted with 5 mL of methanol and subsequently taken to dryness. To remove low molecular weight contaminants the residue was redissolved in 2· 0 mL deionized water with the aid of sonication and transferred to a Sephadex G25-M PDIO column. Gangliosides, forming high molecular weight micelles, were eluted in the void volume by applying 3· 5 mL deionized water. The eluate was taken to dryness in a vortex evaporator (Buchler, Braunschweig, Germany), redissolved in 20 J.tL of methanol and applied onto a HPTLCplate. The plate was run in C/M/Hp 50140/10 vIvIv containing 33 mM KCl (final concentration) and stained using resorcinol-HC!. 9 Gangliosides in resorcinol positive bands were quantified by densitometry (LKB laser scanner, Pharmacia LKB, Sweden) using G M1 as a standard.
Gangliosides from CSF (1' 0 mL) were extracted with 5 vol of CIM 2/1 (vIv) and purified as described above with the following modification. The lower phase was washed twice with 1 vol of M/H 20 1/1.
For the extraction of gangliosides from fibroblasts, the pellet (10 6 cells), chilled in ice, was homogenized in 5 vol of C/M 1/1 vlv for 5 min using a glass potter homogenizer, sonicated and homogenized again for 5 min. Chloroform and deionized water, 2·5 vol each, were added. The gangliosides were purified by a Folch partition procedure, reversed phase chromatography and gel filtration and applied on to an HPTLC plate as above.
Ganglioside loading of cultured fibroblasts
Fibroblasts from a normal control and a patient with infantile Sandhoff disease (case 4) were grown in 25 ern flasks containing 4· 0 mL of medium (TC 199 with 25OJo foetal calf serum and Earls balanced salt solution) on 4·0 mL of G MI enriched (2' 5 mg/flask) medium. Five days later cells were washed with fresh medium and harvested by trypsinization, washed with 10 mL of fresh medium and with phosphate buffered saline solution. The resulting fibroblast pellets were extracted, run on TLC and quantitated as described above. Under normal circumstances the terminal galactose residue in GMI-ganglioside is released by the lysosomal {j-galactosidase and the resulting GM 2-ganglioside with terminal {j-Nacetylgalactosamine is then degraded to G M3 by {j-hexosaminidase. In GM 2-gangliosidosis, this last enzyme is deficient and loading with GMI-ganglioside will result in an increased G M2-content.
RESULTS
Comparison with other extraction procedures
Ganglioside extraction and purification procedures for plasma described in the literature'A? resulted in preparations containing contaminants ( Fig. 1 ) and there was variation in Rj-values between samples. From their brown colour after resorcinol staining these contaminants were judged to be of non-ganglioside origin. Figures 2 and 3 show the chromatograms when the procedure described here is used to extract and purify gangliosides from plasma and fibroblasts. These chromatograms are good enough to be analysed by densitometry.
Leenders, de long and Wevers
To establish linearity and recovery for the whole procedure GMI-ganglioside was added to plasma in increasing amounts. Surface area after densitometric scanning of TLC chromatograms obtained from samples after extraction was compared with that of the same amount of ganglioside applied directly on the TLC plate. Over a concentration range of 2·5 to 50l£g/mL. there was a linear relationship between the amount of GMt added and the amount recovered (Fig. 4) . The mean recovery was 670/0. Table I shows the results of percentages of GMt and G M 2 in samples from patients with gangliosidosis compared with that of normal plasma. Plasma from patients with GMt-gangliosidosis contain a higher concentration of GMt than normal plasma. (Table 1) Recoveries were calculated using a calibration curve made from a series of GMrganglioside standards applied directly on thin layer chromatography. (Fig. 2, lane 3) had a higher percentage of G M2 than in controls. CSF from the patient with GMrgangliosidosis (Sandhoff) (case 4) showed a band corresponding to GM 2-ganglioside (not shown) and the concentration was estimated to be about Il'&I'mL. In normal CSF no GMrganglioside was detected (not shown). 
Gangliosides in plasma and cerebrospinal fluid from patients with gangliosidosis
Gangliosides in cultured fibroblasts Figure 3 shows the ganglioside pattern in fibroblasts from a normal subject (lane 1 and 2) and patient with Sandhoff disease (lane 3 and 4) grown in normal (lane 1 and 3) and GMI-enriched (lane 2 and 4) medium. G Mr content in fibroblasts from GMrgangliosidosis grown in GMI-enriched medium was high. The shape and stain of the G M2 spot (lane 4) was irregular. This is most probably due to overloading of the plate. An unknown ganglioside component between the G DIa -and GMI-standards is present in increased amounts in the ganglioside preparations obtained from the patient's fibroblasts grown in both normal and GMI-enriched medium. The intensity of this band was not increased after loading. Table 2 shows the results of the densitometric quantification of the fibroblast-gangliosides. The difference in GMrcontent between patient and control is more pronounced when fibroblasts are grown in GMI-enriched medium.
DISCUSSION
Due to the low concentration of gangliosides in plasma, careful sample preparation is required to remove contaminants. Compared to previously reported methods,4,6,7 the new procedure gave better thin layer chromatographic patterns (Figs  1-3) . The procedure of Ladisch and Gillard 6 based on diisopropyletherlbutanol extraction and gel filtration gave preparations which had contaminants (Fig. I) . Recovery in our procedure which is based on a combination of reversed phase and gel chromatography was 670/0. It has been reported, however, that the recoveries of the SepPak C I8 reversed phase chromatography'? and the Sephadex gel filtration? are almost quantitative. Lower recovery is probably due to the strong binding of gangliosides to protein.
Trbojevic-Cepe and Kracun'! have described this phenomenon for polysialogangliosides and G M1. The recovery of polygangliosides and G MI from 5 mL of cerebrospinal fluid were 57% and 79%, respectively when O·5 mL of albumin (50 giL) was added. The procedure described here can detect the infantile forms of the diseases. In the juvenile forms the increase in specific plasma gangliosides was not as pronounced as in infantile forms as the accumulation of G M1 and G M2 in juvenile and adult forms is less than that in the infantile forms,2·3 due to higher residual enzyme activity. The new method is also applicable to CSF. A clear G M2-band was seen in CSF from case 4. This is abnormal as G M2 is not a normal component of CSF. 11 We did not analyse urine samples as gangliosides are apparently not excreted in urine'! due to their accumulation in tissues and due to the strong binding to plasma proteins. I I With the procedure described here differences in ganglioside content and composition of fibroblasts between gangliosidosis and normal controls was demonstrated especially after loading with G M1. In fibroblasts from GM 2-gangliosidosis a ganglioside component (double band) between the G Dl a -and GMI-standards was seen ( Fig. 3 ). Apparently these fibroblasts store a second ganglioside, with a terminal N-acetylgalactosamine group and this compound has been suggested to be G D2 or GD,b-GaINAc (GD1b-ganglioside containing an additional terminal GalNAc group). 13 The method described here, based on resorcinol staining, can be used in the microgram (nanomol) range but it is not as sensitive as methods based on immunostaining!"" which can be used in the Ann Clin Biochem 1995: 32 femtomol-picomol range. These immunostaining techniques, however, do not cover the whole range of gangliosides. The cholera toxin affinity based procedure" detects the gangliotetraose series (G M1, G Dl a , G D1b, G T1b) but not G M2 and G M3. Furthermore G M2 specific antibodies are not commercially available." These methods, however, are very useful for analysis of CSF where concentrations are even lower than in plasma.
We conclude that the procedure described here can be of value in the diagnosis of lysosomal diseases especially in cases where there is a deficiency of the activator protein and more generally in the detection and analysis of tumour associated gangliosides, which are potential tumour markers.s-!?
